ICCVAM Advisory Committee

https://ntp.niehs.nih.gov/go/892832

The ICCVAM Authorization Act established the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM). SACATM advises the Director of NIEHS, NICEATM, and ICCVAM about NICEATM and ICCVAM activities.

SACATM, which is directed by its charter to meet at least once each fiscal year, met in September 2018 and September 2019.

Roster of SACATM Members 2018-2019

Name	Title	Company	Appointment End Year
Michael B. Bolger, Ph.D.	Chief Scientist	Simulations Plus, Inc., Lancaster, CA	2020
Joseph L. Charest, Ph.D.	Biomedical Solutions Program Manager	The Charles Stark Draper Laboratory, Inc., Cambridge, MA	2022
Amy Clippinger, Ph.D.	Director	PETA International Science Consortium Ltd., Washington, DC	2022
Kelly P. Coleman, Ph.D., DABT, RAC	Distinguished Scientist and Technical Fellow	Medtronic PLC, Minneapolis, MN	2020
K. Nadira De Abrew, Ph.D.	Senior Scientist (Toxicologist)	The Procter & Gamble Company, Cincinnati, OH	2022
Sean C. Gehen, Ph.D., DABT	Regulatory Sciences Team Leader	Corteva Agriscience, Indianapolis, IN	2022
Hisham K. Hamadeh, Ph.D., DABT, M.B.A.	Vice President, Global Head of Data Sciences	Genmab US, Inc., Princeton, NJ	2019
William P. Janzen	Executive Director of Lead Discovery	Epizyme, Inc., Cambridge, MA	2018
Lawrence Milchak, Ph.D., DABT	Senior Manager, Toxicology and Strategic Services	3M Corporation, St. Paul, MN	2019
Pamela Spencer, Ph.D., DABT	Director of Regulatory and Product Stewardship	ANGUS Chemical Company, Buffalo Grove, IL	2019
ClarLynda Williams-Devane, Ph.D.	Associate Professor of Mathematics and Computer Science; Discipline Coordinator of Bioinformatics	Fisk University Nashville, TN	2020
Wei Xu, Ph.D.	Associate Professor, Department of Oncology	McArdle Laboratory for Cancer Research, University of Wisconsin at Madison, Madison, WI	2018
Hao Zhu, Ph.D.	Assistant Professor, Department of Chemistry	Rutgers University, Camden, NJ	2019

Tags:

COVID-19 is an emerging, rapidly evolving situation.